Literature DB >> 25520451

Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.

Lina Zhao1, Jing Zhang1, Beiwen Zheng1, Zeqing Wei1, Ping Shen1, Sujuan Li1, Lanjuan Li1, Yonghong Xiao2.   

Abstract

The high frequency of fluoroquinolone resistance in Escherichia coli is a feature of clinical bacteriology in China, where the molecular epidemiology and genetic characteristics of this resistance in county hospitals remain unclear. A total of 590 nonduplicate E. coli isolates from 30 county hospitals located across seven Chinese regions were examined for plasmid-mediated quinolone resistance (PMQR) genes and mutations in quinolone resistance-determining regions (QRDRs). Multilocus sequence typing (MLST) and phylogenetic analysis of fluoroquinolone-resistant isolates were used to determine their genetic relatedness. The ciprofloxacin resistance rate of community-onset E. coli was 51.2%, and at least one PMQR gene was carried by 220 (37.3%) isolates. These included qnr (3.7%), aac(6')-Ib-cr (19.7%), qepA (14.4%), and oqxAB (3.8%). Two novel oqxB mutants were identified and named oqxB20 and oqxB29. From 60 sequence types (STs) isolated, 5 novel STs (ST4499 to ST4503) were identified. ST1193 (7.9%) was the second most abundant ST among fluoroquinolone-resistant isolates (ST131 was the most common, with 14.6%), and this is the first report of it in China. This is also the first report of ST2115 and ST3014 isolates from human samples. Ciprofloxacin-resistant E. coli isolates fell mainly into phylogroups B2 and D. The rates of fluoroquinolone resistance and the prevalence of PMQR genes in community-onset E. coli isolates from Chinese county hospitals were high. The wide-ranging molecular epidemiology of E. coli isolates from scattered locations across China indicates that fluoroquinolone resistance evolved from different sources.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25520451      PMCID: PMC4390631          DOI: 10.1128/JCM.02594-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China.

Authors:  Yanchun Wang; Shengyuan Zhao; Lizhong Han; Xiaokui Guo; Min Chen; Yuxing Ni; Yan Zhang; Zelin Cui; Ping He
Journal:  J Antibiot (Tokyo)       Date:  2014-07-02       Impact factor: 2.649

2.  Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.

Authors:  Aylin Colpan; Brian Johnston; Stephen Porter; Connie Clabots; Ruth Anway; Lao Thao; Michael A Kuskowski; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Clin Infect Dis       Date:  2013-08-06       Impact factor: 9.079

3.  Coastal seawater bacteria harbor a large reservoir of plasmid-mediated quinolone resistance determinants in Jiaozhou Bay, China.

Authors:  Jing-yi Zhao; Hongyue Dang
Journal:  Microb Ecol       Date:  2012-01-18       Impact factor: 4.552

4.  Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.

Authors:  James R Johnson; Carl Urban; Scott J Weissman; James H Jorgensen; James S Lewis; Glen Hansen; Paul H Edelstein; Ari Robicsek; Timothy Cleary; Javier Adachi; David Paterson; John Quinn; Nancy D Hanson; Brian D Johnston; Connie Clabots; Michael A Kuskowski
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

5.  Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals.

Authors:  Xiaoli Cao; Lina M Cavaco; Yuan Lv; Yun Li; Bo Zheng; Pengyuan Wang; Henrik Hasman; Yucun Liu; Frank M Aarestrup
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

6.  Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.

Authors:  James A Karlowsky; Heather J Adam; Marc Desjardins; Philippe R S Lagacé-Wiens; Daryl J Hoban; George G Zhanel
Journal:  J Antimicrob Chemother       Date:  2013-05       Impact factor: 5.790

7.  Escherichia coli phylogenetic group determination and its application in the identification of the major animal source of fecal contamination.

Authors:  Camila Carlos; Mathias M Pires; Nancy C Stoppe; Elayse M Hachich; Maria I Z Sato; Tânia A T Gomes; Luiz A Amaral; Laura M M Ottoboni
Journal:  BMC Microbiol       Date:  2010-06-01       Impact factor: 3.605

8.  Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China.

Authors:  Minggui Wang; John H Tran; George A Jacoby; Yingyuan Zhang; Fu Wang; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

9.  Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.

Authors:  Cheol-In Kang; Min Kyeong Cha; So Hyun Kim; Kwan Soo Ko; Yu Mi Wi; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  J Korean Med Sci       Date:  2013-07-03       Impact factor: 2.153

10.  Dominance of CTX-M-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China.

Authors:  Shu Xia; Xin Fan; Zengguang Huang; Liang Xia; Meng Xiao; Rongchang Chen; Yingchun Xu; Chao Zhuo
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

View more
  23 in total

Review 1.  SOS response and its regulation on the fluoroquinolone resistance.

Authors:  Ting-Ting Qin; Hai-Quan Kang; Ping Ma; Peng-Peng Li; Lin-Yan Huang; Bing Gu
Journal:  Ann Transl Med       Date:  2015-12

2.  qnrE1, a Member of a New Family of Plasmid-Located Quinolone Resistance Genes, Originated from the Chromosome of Enterobacter Species.

Authors:  Ezequiel Albornoz; Nathalie Tijet; Denise De Belder; Sonia Gomez; Florencia Martino; Alejandra Corso; Roberto G Melano; Alejandro Petroni
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  Phylogenomic Analysis of Extraintestinal Pathogenic Escherichia coli Sequence Type 1193, an Emerging Multidrug-Resistant Clonal Group.

Authors:  Timothy J Johnson; Ehud Elnekave; Elizabeth A Miller; Jeannette Munoz-Aguayo; Cristian Flores Figueroa; Brian Johnston; Daniel W Nielson; Catherine M Logue; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

4.  Unravelling the antibiotic and heavy metal resistome of a chronically polluted soil.

Authors:  Lateef Babatunde Salam
Journal:  3 Biotech       Date:  2020-05-07       Impact factor: 2.406

Review 5.  Transferable Mechanisms of Quinolone Resistance from 1998 Onward.

Authors:  Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

Review 6.  Escherichia coli ST1193: Following in the Footsteps of E. coli ST131.

Authors:  Johann D D Pitout; Gisele Peirano; Liang Chen; Rebekah DeVinney; Yasufumi Matsumura
Journal:  Antimicrob Agents Chemother       Date:  2022-06-06       Impact factor: 5.938

Review 7.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

8.  Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.

Authors:  Muniqui S Capett; Patricia Vollú-Silva; Vanessa A Melchiades; Luciana C Bokehi; Fernanda M Araújo; Ianick Souto Martins; Felipe P G Neves; Alice G M Gonzalez; Eric Oswald; Geraldo R de Paula; Lenise A Teixeira
Journal:  Curr Microbiol       Date:  2016-07-26       Impact factor: 2.188

9.  Molecular characteristics of the new emerging global clone ST1193 among clinical isolates of Escherichia coli from neonatal invasive infections in China.

Authors:  Yijun Ding; Jinjing Zhang; Kaihu Yao; Wei Gao; Yajuan Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-28       Impact factor: 3.267

Review 10.  Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis.

Authors:  M J D Dautzenberg; M R Haverkate; M J M Bonten; M C J Bootsma
Journal:  BMJ Open       Date:  2016-03-17       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.